former Senior Vice President, Chief Medical Officer · Akebia Therapeutics, Inc. (AKBA)

Rita Jain

A named executive officer of Akebia Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,306,343

Salary $210,794Stock awards $582,400

FY2018: $1,435,818

5th of 7 named executive officers at Akebia Therapeutics by FY2019 total.

7 named officers on file for Akebia Therapeutics, FY2019

Rita Jain’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • AKBA’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Akebia Therapeutics’s whole pay program stands against its peers

  • Akebia Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AKBA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2020 (DEF 14A).

Free

Get Rita Jain’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Rita Jain compensation by year

Akebia Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Akebia Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$255,384$429,884$210,794
Bonus$0$0$0
Stock awards$0$420,420$582,400
Option awards$1,890,104$411,289$511,149
Non-equity incentive$94,233$172,225$0
Pension and deferred compensation$0$0$0
All other$2,000$2,000$2,000
Total$2,241,721$1,435,818$1,306,343

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Akebia Therapeutics, Inc. DEF 14A filed April 23, 2020, accession 0001193125-20-117181, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Akebia Therapeutics, Inc. filed document, accession 0001193125-20-117181. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2020.

$2.2M
$1.4M
$1.3M
FY17
FY18
FY19
SalaryNon-equity incentiveStock awardsOption awardsAll other

Akebia Therapeutics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
John ButlerPresident and Chief Executive Officer$4,316,964
Jason AmelloFormer Senior Vice President, Chief Financial Officer and Treasurer$1,495,724
Michel DahanSenior Vice President, Chief Operating Officer$1,485,247
Nicole HadasSenior Vice President, Chief Legal Officer and Corporate Secretary$1,415,042
Rita Jain · this pageformer Senior Vice President, Chief Medical Officer$1,306,343
Dell FaulkinghamSenior Vice President, Chief Commercial Officer$1,241,702
Steven BurkeSenior Vice President, Chief Medical Officer$1,074,574

The full Akebia Therapeutics compensation record

free company brief

This page is one person within Akebia Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Akebia Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Akebia Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Rita Jain's compensation dossier · One-time report. No refunds.